In June 2013, Mirati Therapeutics, Inc. became the ultimate parent corporation of MethylGene Inc. and subsidiaries by a court and shareholder-approved plan of arrangement.
Here you will find a summary of Mirati Therapeutics Inc.'s latest financial information.
Latest Earnings Release and 10-Q
|Third Quarter Financial Results||N/A|
|Third Quarter Form 10-Q||Nov 12, 2013||452.5 KB|
|Second Quarter Form 10-Q||Aug 13, 2013||492.8 KB|
Latest Annual Report
|2012 Annual Report||955.2 KB|
Subscribe to News
Please fill out the form below to be added to Mirati's press release distribution list.